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a b s t r a c t
It is known that oral administration of sodium tungstate preserves the pancreatic beta cell function in dia-
betic rats. Healthy and streptozotocin-induced diabetic rats were treated with sodium tungstate for one,
three or six weeks, after which the species of W in serum, were analysed. An increase in serum W with
treatment time was observed. After six weeks, the serum W concentration in diabetic rats (70mgL−1)
was about 4.6 times higher than in healthy specimens. This different behaviour was also observed for Cu
accumulation, while the Zn pattern follows the contrary. The patterns observed in the retention of Cu and
Znmaybe attributable to a normalization of glycaemia. The speciation analysis ofWwas performedusing
2D separations, including an immunoafﬁnity packing and a SEC (Size Exclusion Chromatography) column
coupled to an ICP-MS (Inductively Coupled Plasma Mass Spectrometry) for elemental detection. Ultraﬁl-
tration data togetherwith SEC-ICP-MS results proved that around 80% of serumWwas bound to proteins,
the diabetic rats registering a higher W content than their healthy counterparts. Most of the protein-
bound W was due to a complex with albumin. An unknown protein with a molecular weight higher than
100kDa was also found to bind a small amount of W (about 2%). MALDI-TOF (Matrix-Assisted Laser Des-
orption Ionization Time-of-Flight) analysis of the desalted and concentrated chromatographic fractions
conﬁrmed albumin as the main protein bound to tungstate in rat serum, while no binding to transferrin
(Tf) was detected. The interaction between glutathione and W was also evaluated using standard solu-
tions; however, the formation of complexes was not observed. The stability of the complexes between W
and proteins when subjected to more stringent procedures, like those used in proteomic methodologies
(denaturing with urea or SDS, boiling, sonication, acid media, reduction with -mercaptoethanol (BME)
or DTT (dithiotreitol) and alkylation with iodoacetamide (IAA), was also evaluated. Our results indicate
that the stability of the complexes between W and proteins is not too high enough to remain unaltered
during protein separation by SDS–PAGE in denaturing and reducing conditions. However, the procedures
for in-solution tryptic digestion and for ESI-MS analysis inMeOH/H2O/with 0.1% formic acid could be used
for protein identiﬁcation without large loss of binding between W and proteins.. Introduction
Diabetes mellitus is considered a major public health concern.
n 2008 this disease affected 180 million people worldwide, and
his ﬁgure is expected to rise to 366 million by 2030. In spite
f the introduction of hypoglycaemic drugs, diabetes and related
omplications (neuropathy, nephropathy, retinopathy and poor
irculation) continue to be amajormedical problem. Consequently,
onsiderable research effort is devoted to the development of new
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pharmacological agents for the treatment of diabetes. Recently,
several inorganic elements, including derivates of vanadium [1],
molybdenum [2], cobalt [3] and zinc [4], that mimic the effects
of insulin or increase the action of this hormone have been pro-
posed for the treatment of this disease. Indeed, oral administration
of sodium tungstate has recently emerged as an effective treat-
ment for diabetes [5]. This treatment does not cause signiﬁcant
undesirable side effects and furthermore this compound presents
a low toxicity proﬁle [5]. The effect of tungstate is partly due to
normalization of the activity of sucrase and SGLT1 in the brush-
border membrane of enterocytes [6]. Moreover, several long-term
treatments with tungstate in animal models of diabetes normalize
glycaemia by restoring hepatic glucose metabolism [5].
ghts reserved.
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Streptozotocin (STZ)-induced diabetes in rats is an interest-
ng model because it triggers insulinopenic diabetes, which, as in
uman type 1 diabetes [7], involves the impairment of the immune
ystem. Type 1 diabetes results from the selective destruction of
nsulin-producing beta cells in pancreatic islets [8]. The protec-
ive effect of tungstate on SZT-induced pancreatic damage has been
emonstrated in rats [9]. Furthermore, in this animal, female repro-
uctive function, which is impaired in insulin-dependent diabetes
10], is alleviated by a 12-week tungstate treatment, causing partial
ecovery of libido and a signiﬁcant improvement in reproductive
erformance [11]. In addition, tungstate treatment causes a dra-
atic decrease in body weight in healthy and diabetic rats [5]. It
s known that excessive body weight is implicated in the origin of
ype 2 diabetes.
Biospeciation analysis involves highly complex analytical
ethodologies that should have the capacity to overcome draw-
acks such as low concentrations, complex matrices, species
ransformations, and cleavage of the metal–biomolecule bonds. In
eneral, the complexity of the clinical samples makes it necessary
o perform prior fractionation/separation steps for the isolation of
etal–biomolecule complexes [12]. Recent years have witnessed
he introduction of complementary analytical techniques, like tan-
em HPLC-ICP-MS, for the separation of the metal-containing
pecies and on-line high sensitive detection of themetal, and struc-
ural Mass Spectrometry (MS) techniques, such as MALDI-TOF and
lectrospray Ionization (ESI)-MS [13,14].
A HPLC-ICP-MS method for W speciation in protein model solu-
ions and in spiked human serum has been described [15]. W
howed a high tendency to be retained in the chromatographic
olumns. Size Exclusion Chromatography (SEC) coupled to ICP-
S with a Phenomenex Bio-SepS 2000 column, and 150mM NaCl
n 20mM HEPES pH 7.4 as mobile phase, provided quantitative
ecovery of W species from the column and was chosen to screen
or W-protein species and free W. W in protein model solutions
orms complexes with albumin and, to a lesser extent, with apo-
ransferrin (apo-Tf) following a fast kinetic process that is not
uantitative. Conversely, there is no interaction between W and
mmunoglobulin-G (IgG) or2-macroglobulin. In vitro studieswith
piked human serum revealed the formation of W-albumin com-
lex (45%) and a signiﬁcant amount of free W (30–40%). These
esults are in contrast with those reported for antidiabetic VIVO
ompounds when orally administrated and show Tf as the main
IVO transporter in serum in vivo. This associationwas independent
f the chemical form in which VIVO was administered [16].
To understand the transport and metabolism of W in animal
odels, a biospeciation study of this element in serum from dia-
etic and healthy rats after oral intake of sodium tungstate for
iabetes treatment have been done. Several analytical approaches
ased on the use of 2D separations by SEC-ICP-MS, ultraﬁltration
nd immunoafﬁnity, and MALDI-TOF to characterize the protein
oieties associated with W fractions of the serum were done. The
trength of the bonds between W and proteins when subjected
o high denaturing procedures, like those employed in proteomic
nalysis, was also evaluated.
. Experimental
.1. Reagents and materials
All chemicals were of analytical grade. All solutions were
repared in de-ionised water (Milli-Q Ultrapure water systems,
illipore, USA). Standard solutions were prepared from stock solu-
ions of W, Cu, Zn, Rh, Pt and Ir (1000mgL−1, Merck), diluted
ith 5% HNO3 to the concentrations required. Human serum albu-
in (HSA), reduced l-glutathione (GSH), iodoacetamide (IAA),nta 84 (2011) 1011–1018
dithiotreitol (DTT), urea, sodium dodecyl sulfate (SDS) and -
mercaptoethanol (BME) were purchased from Sigma Aldrich.
Tris(hydroxymethyl)aminomethane (Tris), triﬂuoracetic acid (TFA)
and formic acid (HCOOH) were from Fluka. HPLC grade acetoni-
trile (ACN) and methanol (MeOH) were purchased from Scharlab.
The HPLC mobile phase used was a 20mM [4-(2-hydroxyethyl)-
piperazine-1-(2ethanesulfonic acid)] (HEPES) buffer (pH 7.4)
(Sigma–Aldrich) with 150mM NaCl (Panreac). High-purity nitric
acid and hydrochloric acid, used for pH adjustment of the chro-
matographic mobile phase and other buffers, were obtained by
distillation of the analytical grade reagents (Merck). Sinapinic acid
(Fluka), TFA and ACN were used for MALDI-TOF analysis. Microcon
YM centrifugal devices (3, 10, 30, 50 and 100kDa cut-off ﬁlters)
were purchased from Millipore. A 5804 R centrifuge (Eppendorf), a
dry bath for Eppendorf heating (Labnet International), a sonication
bath (Selecta) and a pH-meter (Crison) were used.
2.2. Animals and treatment protocols
Adult female Wistar rats (200g) were housed at 22 ◦C in a light-
controlled (12-h cycle) animal facility and had free access to food
andwater.When stated, diabeteswas inducedby a single intraperi-
toneal injection of STZ (70mgkg−1 of body weight) in 0.9% NaCl
with 100mM sodium citrate buffer (pH 4.5). Diabetes was con-
ﬁrmed by measuring glycemia. Diabetic rats were used 5–7days
after STZ injection, when serum glucose exceeded 500g L−1. Dia-
betic and healthy ratswere divided into two groups. The ﬁrst group
(untreated) received drinking water, while the second (treated)
received a solution of 2 g L−1 sodium tungstate in water. Fluid and
food intakes as well as body weight were controlled regularly for
1, 3 and 6weeks. At the end of the experiments, rats were anes-
thetizedwithdiethyl ether anddecapitatedbetween9.00and10.00
am. Blood was collected immediately and the serum was separated
from coated cells by centrifugation.
Animals were handled following the guidelines of the National
Council for Care of Laboratory Animals.
2.3. Analysis of W, Cu and Zn by ICP-MS
A quadupole ICP-MS Thermo X-Series (Thermo Electron)
equippedwith aMeinhardnebulizer for slurry analysis (∅150m),
a Fassel torch and an impact bead quartz spray chamber cooled by
a Peltier system was used for W, Zn and Cu determination. ICP-
MS operating conditions were as follows: forward power 1250W,
plasma gas 15 Lmin−1, auxiliary gas 0.73 Lmin−1, nebulizer gas
0.85 Lmin−1, channels per AMU 10 and integration time 0.6ms.
Sample was introduced in continuous mode and single-ion mon-
itoring of m/z 184 (W), 186 (W), 65 (Cu), 66 (Zn) and 191 (Ir)
was used to collect data. Before analysis, serum samples were cen-
trifuged at 12,000× g at 4 ◦C for 5min and the supernatants were
diluted with 2% (v/v) HNO3 for analysis. Quantiﬁcation was per-
formed using external calibration in a working range between 50
and 1200g L−1. We used 250g L−1 of Ir as internal standard.
2.4. W speciation by SEC-ICP-MS
Speciation studies were performed using a LC-ICP-MS hyphen-
ated system. A high pressure quaternary gradient pump (Jasco
PU-2089) equipped with a 200-L sample injection valve (Rheo-
dine) was used as the delivery system. Two types of SEC column
were used to separate the proteins bound to W: (a) Phenomenex
Bio-Sep-S 2000 (Pharmacia Biotech), with a separation range of
1–300kDa, and (b) Superdex 75 10/300 column (Pharmacia Cor-
poration, 300×7.8mm id), with a separation range 3–70kDa. The
ﬂow rates were 1 and 0.8mLmin−1, respectively. Serum samples
were diluted 10–50-fold with the mobile phase (HEPES buffer pH
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Table 1
Study of the stability of the complexes between W and proteins in the serum of treated diabetic rats under the conditions used in SDS–PAGE protein separation, tryptic
digestion and ESI-MS analysis. Results are presented as the percentage of recovery from the original W-protein fraction after ultraﬁltration.
Break-through fraction Retained fraction % Recovery
Treatment W-inorganic
(mgL−1)
W-proteins
(mgL−1)
W-proteins Total W
Raw sample – 12.3 100 100
1% SDS+62.5mM Tris–HCl (pH 6.8) 3.1 8.7 76 96
1% SDS+62.5mM Tris–HCl (pH 6.8), UW (10min) 4.7 2.7 22 60
1% SDS+62.5mM Tris–HCl (pH 6.8), 100 ◦C (5min), UW (10min) 4.9 1.2 10 49
1% SDS+62.5mM Tris–HCl (pH 6.8) +5%BME 4.1 2.0 17 49
1% SDS+62.5mM Tris–HCl (pH 6.8) +5% BME, 100 ◦C (5min), UW (10min) 2.4 2.5 22 40
70% ACN+0.1% HCOOH 0.81 2.8 24 29
50% ACN 0.78 4.2 36 40
50% MeOH 0.83 8.9 78 79
0.1% HCOOH 1.3 7.2 62 68
50% ACN+0.1% HCOOH 0.76 2.4 21 26
0.9
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b50% MeOH+0.1% HCOOH
8M urea+50mM NH4HCO3 +10mM DTT (37 ◦C, 1h) +50mM IAA (1h)
W: sonication.
.4 with 150mM NaCl) and passed through a 0.22-m Millex GV13
lter (Millipore) before injection into the chromatographic system.
or W detection, transient single mode was set, monitoring m/z
84 (W) and 186 (W). 50g L−1 of iodide, as NH4I, was used as
nternal standard for correction of signal drift. Quantiﬁcation of
oth W species (organic and inorganic tungstate) was performed
y external calibration of inorganic tungstate.
.5. Fractionation of rat serum by ultraﬁltration and SEC-ICP-MS
Rat serum was diluted 10-fold with Milli-Q water and injected
nto the Superdex 75 10/300 SEC-column. The fractions with a
igh W content (8.3–10.1min, 10.3–13.3min and 19.4–21.0min)
ere collected in polypropylene tubes. The same fractions, from
wo separate runs (about 3.2mL), were pooled, ﬁltered and con-
entrated by ultra ﬁltration using centrifuge ﬁlters with molecular
ut-off points of either 3, 10, 30, 50 or 100kDa (Amicon, Millipore).
entrifugationsweremadeat 7500× g, 4 ◦C for 35minand the sam-
les retained were diluted with water to 250L. Both retained and
reak-through fractions were later analysed by SEC-ICP-MS.
.6. Depletion of albumin and IgG by immunoafﬁnity
A commercially available immunoafﬁnity packing for albumin
nd IgG depletion (ProteoPrep, Sigma–Aldrich) was used. This
it contains spin columns in which ProteoPrep immunoafﬁnity
edium is supplied in a prepacked form. Prior to use, columns are
quilibrated by centrifugation (5000× g) for 5–10 s to remove the
torage solution, followed by two washes with 0.4mL of the equi-
ibrium buffer solution provided with the kit. Centrifugations were
ade for 5–10 s at 5000× g. Buffer in the collection tube was dis-
arded and the spin column was place in a fresh collection tube.
liquots of 50L of serum sample were diluted to 100L with the
quilibration buffer and added to the top of the packed medium
ed. The sample was immediately adsorbed into the medium, thus
nsuring efﬁcient binding of albumin and IgG and minimal sam-
le dilution. Spin columns were incubated at room temperature
or 5–10min and centrifuged at 8000× g for 60 s. To ensure opti-
al depletion of abundant proteins, the eluatewas reapplied to the
op of the spin column, incubated for another 5–10min and cen-
rifuged again for 60 s using the same collection tube. The proteins
hat remained unbound were washed from the column by adding
25L of the equilibration buffer and were then centrifuged for
0 s. Finally, the albumin- and IgG-depleted serum was analysed
y SEC-ICP-MS.7.4 64 67
9.1 79 84
2.7. Elucidation of protein Mr by MALDI-TOF-MS
Mass analyses of proteins that potentially bind to W were
performed by MALDI-TOF (Voyager DE-PRO, Applied Biosystems).
Fractions eluting from the SEC column at 10.3–13.3min were col-
lected in polypropylene tubes. A pool of identical fractions from
two separate runs were desalted and concentrated in cut-off ﬁlters
of 30kDa by centrifugation at 5000× g and 4 ◦C for 1h. The reten-
tate was made up to 100L with ultrapure water. These aliquots
were mixed with a saturated sinapinic acid solution in 0.1% (v/v)
TFA: ACN to measure the molecular mass of proteins by MALDI-
TOF. The operating parameters used were as follows: detector,
linear mode; accelerating voltage, 25kV; grid, 95%; guide wire, 0.2;
delay time, 500ns. Acquisition was made in the m/z range between
30,000 and 75,000kDa. A total of 100 shots were made per spec-
trum, and six spectra were accumulated per sample in order to
increase the S/N ratio. Spectra were acquired in positive ion mode.
The analysis was performed by external calibration of the instru-
ment by placing several aliquots of a standard solution of human
serum albumin (Mr 66,554) in alternative holes of the MALDI
plate.
2.8. Incubation of glutathione with W
A solution of 500MGSHwas incubatedwith sodium tungstate
(10mgL−1 as W) at 37 ◦C for, 2, 4, 24, 48, 144 and 360 and 480h in
two saline solutions: (a) 5mM NaCl in a 20mM HEPES buffer at pH
7.4 and (b) 25mM NaCl in a 20mM Tris–HCl buffer at pH 7.4. The
analyses of these solutions after the incubations were performed
by SEC-ICP-MS.
2.9. Stability of the complexes between tungstate and proteins
Aliquots of 40-L of rat serum samples were diluted to 250L
with the chromatographic mobile phase. The W bound to pro-
teins was isolated from the unbound fraction by ultraﬁltration
with a 10kDa cut-off ﬁlter and centrifugation (14,000× g). The
retained fraction (about 40L) was recovered and subjected to one
or more of the treatments shown in Table 1, such as denaturing
with urea, heating, sonication, acid media, reduction of disulﬁde
bonds with BME, and blocking of the free thiols generated by alky-
lation with IAA. After these treatments, samples were ultraﬁltrated
again and the retained and ﬁltrated solutions were analysed by
FI-ICP-MS.
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Fig. 1. SEC-ICP-MS chromatograms obtained with a column Phenomenex Bio/Sep014 M.M. Gómez-Gómez et al.
. Results and discussion
.1. W accumulation in diabetic and healthy rats after treatment
ith sodium tungstate
The concentration of W in the serum of treated rats increased
ith the treatment time (Table 2). As a general trend a more pro-
ounced increased of W in serum from diabetic than for healthy
ats was observed. The ratios of W content for diabetic compared
o healthy rats were 3.2-, 2.7- and 4.6-fold after 1, 3 and 6weeks of
reatment, respectively. Diabetes induces a great intake of water.
onsequently, for an appropriate evaluation of the accumulation
f W, along with the weight of the rats, the amount of W ingested
uring the treatment must be taken into consideration. The aver-
ge amount of tungstate ingested in the 6-week treatment was
23±114mgkg−1 day−1 and 205±25mgkg−1 day−1 for diabetic
nd healthy rats, respectively. These ﬁgures imply that diabetic rats
ngested 3 times more tungstate than their healthy counterparts,
hus accounting for the higher W concentration found.
Administration of sodium tungstate to diabetic rats normalized
lycemia. No undesirable side-effects were detected and a general
ood state of health was observed. Moreover, these rats showed
signiﬁcant loss of body weight. This effect could be considered
n additional beneﬁt of the treatment as it is known that body
eight gain is one of the factors involved in diabetes mellitus type
. Tungstate treatment did not modify daily food and water con-
umptionhabits in healthy rats, althougha signiﬁcant decreasewas
bserved in diabetic ones, reaching values that were only slightly
reater than those observed for treated and untreated healthy rats.
Given that Cu and Zn are involved in glucose metabolism, the
ontent of these metals in the serum of the four experimental sets
fter 6weeks treatment was evaluated. The concentration of Cu
as 2.4-fold higher in diabetic than in healthy ones (Table 2). These
esults may be explained by the fact that Cu is crucial for the cat-
lytic activity of the enzymes cytochromeCoxidase and superoxide
ismutase, both thought to be involved in diabetes as a result of
heir participation in the regulation of intracellular redox status.
n increase in Cu concentration has been reported in the liver and
idney of STZ-diabetic rats [17] and has been linked to diabetes
18]. Abnormalities in Cu metabolism appear to be a consequence
f the disease.
Insulin is produced in the -cells of the pancreatic islets as
hexamer around Zn. Patients with diabetes suffer from hypoz-
ncemia as a result of failure of -cell production, which ﬁnally
ffects insulin levels [19]. Our results are consistent with this ﬁnd-
ngaswedetected a1.8-foldhigher Zn concentration inhealthy rats
han in diabetic ones after sodium tungstate treatment (Table 2).
.2. W speciation by SEC-ICP-MS
Here we applied methodology previously reported [15] to test
he speciation ofW in the serumof diabetic andhealthy rats treated
ith sodium tungstate for 1, 3 and 6weeks. Fig. 1c shows the
hromatogram obtained by SEC-ICP-MS, using a SEC column Phe-
omenex Bio/Sep 2000 with a separation range of 1–300kDa, from
serumsampleof adiabetic rat treated for6weeks. Thecomparison
f this chromatogramwith thoseobtainedwith tungstate standards
1b) and a solution of albumin incubated in vitro with tungstate
1a), allows the assignation of the two main peaks observed: at
.6min the complex W-albumin and at 9.5min free W. In a previ-
us work quantitative column recoveries for the W species were
btained [15]. To improve the chromatographic resolution, a SEC
olumn with a separation range between 3 and 70kDa was tested
a Superdex 75 10/300). Fig. 2c shows the chromatogram obtained
or this column, where three peaks were observed in the chro-
atogram of a same serum sample. The main peak at 11.3min2000 (1–300kDa) of: (a) a standard solution of 5mgL−1 HAS incubatedwith 5g L−1
tungstate in0.9%NaCl and10mMHEPEsbuffer (pH7.4) for 2h, (b) 5g L−1 tungstate
and (c) a serum of a diabetic rat treated for 6weeks with sodium tungstate.
matches the W-albumin complex while that at 20.2min matches
freeW.However, the new small peak at 9.2min does notmatch any
of the previously characterized W compounds, and corresponds to
a W-protein species with a higher molecular weight than albumin
that elutes in the column exclusion volume. The same chromato-
graphic proﬁle for a healthy rat treatedwith tungstate for sixweeks
was obtained (Fig. 2b). Secondary interactions of the species with
the stationary phase may explain the higher resolution obtained
with this column, as compared to the Phenomenex Bio/Sep 2000
column, for the separation of W-serum protein complexes. Quan-
titative recoveries for both columns were obtained.
For the quantiﬁcation of free W and protein-bound W species
by SEC-ICP-MS, the use of an internal standard that corrects for
potential instrumental drifts in the analysis, especially in the case
of mobile phases with high saline content, is recommended. Solu-
tions of Pt, Rh, Ir and NH4I were diluted in the chromatographic
mobile phase and tested for their suitability as internal standards.
Iodide that elutes at 11.6 and 25.2min from the Phenomenex and
the Superdex columns, respectively, showed the best performance
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Table 2
W Cu and Zn concentrations in rat serum of diabetic and healthy rats treated with sodium tungstate for 1, 3 and 6weeks.
Animals Sample [W] (mgL−1) [Cu] (mgL−1) [Zn] (mgL−1)
1 week of treatment
Diabetic 1 26.9 – –
2 28.1 – –
27.5±0.8
Healthy 1 8.1 – –
2 8.8 – –
Average ± s.d 8.5±0.5
3weeks of treatment
Diabetic 1 34.0 – –
2 27.2 – –
3 37.5 – –
4 28.0 – –
5 31.0 – –
Average± s.d 32±4
Healthy 11.4 – –
12.0 –
12.2 – –
11.4 – –
Average± s.d 11.7±0.4 – –
6weeks of treatment
Diabetic 1 86 26.2 140
2 62 19.3 133
3 62 17.6 77
4 71 20.6 80
Average± s.d 70±11 21±4 108±33
Healthy 1 14.5 8.3 171
2 16.6 10.4 239
3 14.6 8.4 202
4 14.5 8.6 139
Average± s.d 15±1 9±1 188±43
The W content in untreated diabetic and healthy rats was 0.019±0.005mgL−1. Hum
9.6±4.2mgkg−1). Found values (Cu: 11.9±0.9mgkg−1, Zn: 10.1±0.8mgkg−1).
Fig. 2. Speciation of tungstate by SEC-ICP-MS with column Superdex 75 10/300
(3–70kDa) in a) 5g L−1 tungstate in 0.9% NaCl and 10mM HEPEs buffer (pH 7.4),
(b) a serum of a healthy rat treated for 6weeks with sodium tungstate (c) a serum
of a diabetic rat treated for 6weeks with sodium tungstate.an serum CRM University of Gent: certiﬁed values (Cu: 11.1±3.6mgkg−1, Zn:
and was therefore selected as internal standard for subsequent
analysis.
Table 3 shows the results obtained for the W speciation in
the serum samples. The percentage of protein-bound W slightly
increased in healthy and diabetic rats following the treatment.
Between 1 and 6weeks, the increments were from 72 to 82% and
from 52 to 66%, in diabetic and healthy rats, respectively. Inter-
estingly, the percentage of W bound to proteins was consistently
higher for diabetic as compared to healthy rats. This fact may indi-
cate that the treatmentwith tungstate inducesmodiﬁcations in the
metabolism of albumin.
The concentration of W calculated by speciation (as the sum of
the W species) was compared with the total W amounts obtained
by direct analysis of the serum by FI-ICP-MS (Table 3). In gen-
eral, acceptable agreement between the two values was observed,
thus demonstrating the satisfactory performance of the chromato-
graphic method used. It has to taken into account that samples
arised from different animals, and this fact will be reﬂected in the
uncertainty of the results obtained.
3.3. Separation by ultraﬁltration and SEC-ICP-MS
Experimentswere conducted to exclude the possibility of coelu-
tion of minor W-binding proteins with complexes that are as
abundant as W-albumin complexes. Therefore, the purity of the
chromatographic fractions containing W was ﬁrst evaluated by
a sequential separations through cut-off ﬁlters of 3, 10, 50 and
100kDa, as it has beendescribed in Section2.5. The results obtained
show that the peak at 11.3min corresponds to a protein with a Mr
between50and100kDa, therefore, assignation toalbumin-Wcom-
plex is plausible, as theMr for albumin is around66kDa. In addition,
our results show that the peak at 9.2min corresponds to a protein
bound toWwith aMr higher than100kDa, and thepeak at 20.2min
corresponds to free W.
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Table 3
Speciation of tungstate in serum of diabetic and healthy rats treated with sodium tungstate for 1, 3 and 6weeks. Comparison with the total W content calculated using
ICP-MS.
Total W (mgL−1)
Group of animals W-proteins
(mgL−1)
W-inorganic
(mgL−1)
% W-proteins % W-inorganic SEC-ICP-MS ICP-MS
Treatment of 1 week
Diabetic 14 ± 4 5.5 ± 0.1 72 ± 20 28 ± 1 20 ± 4 27.5 ± 0.8
Healthy 3.3 ± 0.8 3.1 ± 0.2 52 ± 12 48 ± 3 6.4 ± 0.8 8.4 ± 0.5
Treatment of 3 week
Diabetic 16.7 ± 0.3 9.2 ± 0.8 64 ± 1 36 ± 3 25.9 ± 0.8 31 ± 4
Healthy 4.8 ± 0.3 6.1 ± 0.6 44 ± 3 56 ± 6 10.9 ± 0.7 11.7 ± 0.4
Treatment of 6 weeks
Diabetic 55 ± 9 13 ± 2 81 ± 13 19 ± 3 68 ± 9 70 ± 11
66 ±
3
S
a
2
a
a
d
a
e
I
s
F
tHealthy 10 ± 2 5.2 ± 0.9
.4. 2D chromatographic separation by immunoafﬁnity and
EC-ICP-MS
The purity of the main chromatographic peak, assigned as
W-albumin complex, was evaluated in a second approach by
D chromatographic separation. Immunodepletion of the most
bundant proteins in serum (albumin and IgG with 65% and 15%
bundance, respectively) was used as the ﬁrst chromatographic
imension. A commercially available depletion kit containing
ntibodies recognising albumin and IgG was used. The reported
fﬁciency for depletion is about 95% and 85% for albumin and
gG, respectively. The depleted serum was ﬁnally subjected to the
econd chromatographic dimension and analysis by SEC-ICP-MS.
ig. 3. SEC-ICP-MS chromatograms of serum from a rat treated with sodium tungstate fo
he proteins that are most abundant in blood (HSA and IgG).13 34 ± 6 15 ± 3 15 ± 6
Themain chromatographic peak at 11.3min disappeared,while the
peaks at 20.2min and 9.2min, corresponding to freeWandWcom-
plexed to the unknown-protein, remained (Fig. 3). These results
conﬁrm the purity of the W-albumin chromatographic peak, which
accounted for 80% of the W present in the serum of the rats after a
6-week treatment with sodium tungstate; while the protein elut-
ing at 9.2min only accounts for 2%. Results obtained for diabetic
and healthy rats were quite similar.3.5. Conﬁrmation of W-albumin complexes by MALDI-TOF-MS
Given the capacity of MALDI-TOF for protein analysis, the iden-
tiﬁcation of the proteins present in the W-protein SEC fractions
r six weeks, either using (a) or not (b), a previous depletion by immunoafﬁnity of
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ith the highest W content was done by MALDI-TOF. In a previous
aper the formation of the tungstate-albumin complex in human
erum incubated in vitro with sodium tungstate was demonstrated
y MALDI-TOF analysis [15].
Themean obtained fromnine different sample target spotswith
heir standard deviations were used to calculate the Mr. The mass
pectra from SEC fractions of samples from the four experimental
roups of rats were registered. However, it should be noted that
lbumin gives awidepeak inMALDI-TOF,which limits the accuracy
f the molecular mass obtained. The molecular ion [M+H]+ for the
reated diabetic rats was observed at m/z 66,859±98Da, which is
ery close to the theoretical value for rat serum albumin (65,912)
ithout posttranslational modiﬁcations. The mass shift observed
ould be due to the glycated albumin which is elevated in the case
f hygerglycemia (nowadays is usedas abiomarker).Nopeakswere
btained for apo-Tf (76,000) in this fraction. Therefore, it can be
oncluded that albumin is the main protein that binds to tungstate
n the serum of rats following this antiabetic treatment, while no
inding to Tf was observed.
.6. Stability of the complexes between W and proteins
Advanced metollo-proteomic analysis of W interaction with
roteins involves the use of well established proteomic method-
logies, such as SDS–PAGE and bottom-up protein identiﬁcation
pproaches with enzymatic digestion, and ﬁnal analysis of the
esulting peptides by MS–MS, using either ESI or MALDI. There-
ore, the evaluation of the stability of the complexes between W
nd proteins when subjected to the diverse treatments used in
hese methodologies is crucial. Denaturing with either urea or SDS,
oiling, sonication, acid media, reduction of disulﬁde bonds with
ME or DTT, and the alkylation reaction of the generated free thiols
ith IAA, were tested. Ultraﬁltration with 10kDa cut-off ﬁlters was
sed to separate inorganic-W, which might be released by these
reatments, from that remaining bound to proteins. Finally, both
ractions were analysed by FI-ICP-MS and the results are shown in
able 1.
Sample preparation for SDS–PAGE, including SDS andBME incu-
ation and boiling produced very low recoveries (around 10–22%)
fWbound toproteins.Nevertheless, the recovery after the incuba-
ion with Tris buffer or 1% SDS was acceptable (76%). Consequently,
e conclude that sonication, heating or reaction with BME pro-
uced deleterious effects on the binding between W and proteins.
When simulating the conditions used for tryptic digestion, i.e.,
reatment with urea, DTT, IAA within a pH range 7.5–8 in NH4HCO3
uffer, acceptable recoveries (79%) were obtained.
We also tested the conditionswidely used in ESI-MS.WhenACN
as used in the spraying solution, considerable losses of W from
roteins were produced, while the use of MeOH or the MeOH and
.1% HCOOH mixture provided acceptable recoveries of 78% and
4%, respectively.
These results suggest that the stability of the complexes
etween W and proteins is not too high enough to withstand the
onditions widely applied in proteomics analysis, protein separa-
ionbySDS–PAGE indenaturing and reducing conditions.However,
he procedures for in-solution tryptic digestion and ESI-MS analy-
is in a MeOH/H2O/with 0.1% formic acid solution could be used for
rotein identiﬁcation without large loss of the binding between W
nd proteins.
.7. Interaction of W with glutathionePatients with diabetes present high levels of intracellular oxida-
ive stress as a result of hyperglycemia and thus decreased capacity
f the redox defence system. According to several diabetic mod-
ls [20], oxidative stress reduces insulin secretion by the pancreas
[
[
[nta 84 (2011) 1011–1018 1017
and increases insulin resistance in target tissues, while the control
of glycemia results in an improved redox protective system. It has
been reported that levels of GSH, an abundant antioxidant metabo-
lite present in cells atmM level, are lower in patients suffering from
diabetes [21]. Metals like Cu, Mn, Mg, Fe, Se, V, Cr and Zn have been
proposed to indirectly participate in the reversal of oxidative stress
[19], with some establishing complexes with GSH, as shown for V
[22].
We evaluated the binding of W with GSH, at concentrations
similar to those present inside the cells. A solution of 10mgL−1
of tungstate was incubated with 500M GSH under conditions
described in Section 2.8. Experimental section and was analysed
by SEC-ICP-MS. The chromatograms consistently showed only the
peak corresponding to the inorganic W, with an area that did not
varywith the incubation time (data not shown). The results suggest
that the interaction between GSH and W does not occurs, as it does
with other heavy metals such as Pt [23].
4. Conclusions
The developed analytical methodology has proven to be effec-
tive to follow the accumulation of W in serum in both diabetic and
healthy rats after oral administration of sodium tungstate. It has
been also demonstrated that albumin is the responsible protein
for W transport after oral treatment. The strength of the bonds
between W and proteins is not strong enough to use classical
proteomic approaches like SDS–PAGE in denaturing and reduc-
ing conditions. Applications of the proposed methodology could
be very useful to perform further metaloproteomic studies in
cell cytosols under non-reducing SDS–PAGE and ESI-MS analy-
sis.
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